s t r a c t
This dataset is related to the research article entitled "May iron(III) complexes containing phenanthroline derivatives as ligands be prospective anticancer agents?" [1] . It includes the characterization by UVeVis absorption spectroscopy and magnetic techniques of a group of mixed ligand Fe(III) complexes bearing a tripodal aminophenolate ligand L 2À , H 2 L ¼ N,N-bis(2-hydroxy-3,5dimethylbenzyl)-N-(2-pyridylmethyl)amine, and different aromatic bases (NN ¼ 2,2 0 -bipyridine [Fe(L)(bipy)]PF 6 (1), 1,10phenanthroline [Fe(L)(phen)]PF 6 (2), or a phenanthroline derivative co-ligand: [Fe(L)(amphen)]NO 3 (3), [Fe(L)(amphen)]PF 6 (3a), [Fe(L)(Clphen)]PF 6 (4), [Fe(L)(epoxyphen)]PF 6 (5) (where amphen ¼ 1,10-phenanthroline-5-amine, epoxyphen ¼ 5,6-epoxy-5,6-dihydro-1,10-phenanthroline, Clphen ¼ 5-chloro-1,10phenanthroline), as well as [Fe(L)(EtOH)]NO 3 (6), [Fe(phen)Cl 3 ] (7) and [Fe(amphen)Cl 3 ] (8). Data on their hydrolytic stability in physiological buffers is shown, as well as on their interaction with calf thymus DNA by spectroscopic tools. Additionally, the anticancer efficacy and the cellular death mechanisms activated in response to these drugs in HeLa, H1299 and MDA-MB-231 cells are provided. [1] .
Value of the Data
The dataset herein may give researchers in anticancer drug development field a reference for comparison with similar compounds or with complexes carrying similar ligands.
The data provides additional insight through confirmation of results in two cell lines in addition to the cell line used in the main study (cervix). This may be particularly useful for scientists, who are interested in lung and breast cancer research. The data is relevant for chemists interested in the hydrolytic stability of Fe(III) complexes and in the cytotoxicity of ternary Fe(III) complexes containing phenanthroline co-ligands. The data may be relevant for researchers using Fe(III) complexes for further mechanistic studies that focus on growth inhibition as a result of apoptosis.
Data
The introduction of a NN aromatic heterocyclic co-ligand, with NN ¼ 2,2 0 -bipyridine (bipy), 1,10phenanthroline (phen) or a 1,10-phenanthroline derivative, in the Fe-coordination sphere, may reinforce their biological activity. Anticancer drugs can exert therapeutic effects through several mechanisms, and the mode of action of Fe(III)-complexes is still matter of debate, with multiple molecular targets possibly being involved. Here we report experimental data on characterization of Fe(III) complexes and their mode of action on human cancer cell lines.
The Fe-aminophenolate complexes [1] were characterized by UVeVis spectroscopy in different solvents (Figs. 1e4) , which allowed the assignment of their spectral bands. Their characterization by magnetic techniques e magnetization versus temperature measurements ( Fig. 5 ) and M€ ossbauer spectroscopy ( Fig. 6 ) -identified them as high spin Fe(III) species.
When developing metallodrugs, species with adequate stability and defined hydrolytic products are required. As metal complexes may suffer aquation, hydrolysis and ligand exchange, information on their hydrolytic stability is of utmost importance. Monitorization of UVeVis spectral changes of the complexes in buffers (pH ¼ 7.4) was done ( Fig. 7) as well as by ESI-MS spectrometry ( Fig. 8 and Table 1 ).
DNA may be a target for the metallodrugs, since phenanthroline molecules are known to intercalate between DNA base pairs. Thus, to elucidate the capability of all compounds to bind DNA, spectroscopic studies were done by circular dichroism (Figs. 9 and 10), UVeVis absorption (Figs. 11 and 12) and fluorescence ( Fig. 13 ). During the execution of apoptosis, cells display marked morphological features such as shrinkage, blebbing or formation of blisters [2] . Many examples of cellular blebs, which appeared as balloon-like protrusions on the membrane, were detected in H1299 and MDA-MB-231 cells (Fig. 14) . Cellular shrinkage and decrease in cell numbers were also evident in a concentration (6.3e50 mM) and time (24, 
Experimental design, materials and methods

Characterization of the complexes
Electronic absorption spectra (UVeVis) were recorded with a Perkin Elmer Lambda 35 spectrometer in DMSO, isopropanol or THF. Magnetisation measurements as a function of temperature were performed using a SQUID magnetometer (Quantum Design MPMS). The curves were obtained at 0.1 T for temperatures ranging from 10 to 300 K. The molar susceptibilities values were corrected for diamagnetism of the constituent atoms.
Hydrolytic stability
Electronic absorption spectra (UVeVis) were recorded with time for complexes dissolved in 3% DMSO/97% Hepes (10 mM, pH 7.4). A LCQ Fleet™ Ion Trap Mass Spectrometer from Thermo Scientific was used to measure ESI-MS spectra of methanolic solutions of the complexes in the positive mode for characterization, and of aqueous solutions (3% DMSO-NaHCO 3 aqueous buffer pH 7.4) for stability experiments. 
DNA binding data
Stock solutions of the complexes were prepared in DMSO. Sample solutions were prepared by dilution of the DMSO stock solution in Hepes buffer. The amount of organic solvent was kept below 4% (v/v). Stock solutions of Calf Thymus DNA (ctDNA) were prepared in Hepes buffer (10 mM, pH 7.4). Electronic absorption titrations were done by adding aliquots of the DNA stock solution to solutions of the complexes (30e55 mM) in 3% DMSO-Hepes. The DNA solution was also added to the reference cell.
Circular dichroism studies were done in quartz SUPRASIL® cuvettes of 10 mm or 5 mm optical path. Hepes buffer or Hepes/DMSO mixtures were used to obtain the baseline, which was subtracted from each spectrum. Spectra were collected from 230 to 500 nm with a resolution of 1 nm band-width, 3 accumulations.
Iodide quenching assay
Stock solutions of [Fe(phen)Cl 3 ] 7, in DMSO, were diluted directly in a quartz cuvette of 1 cm path length containing 3 mL of aqueous Hepes buffer (10 mM, pH ¼ 7.4) solution, giving a final concentration of complex of ca. 14.2 mM (0.7% DMSO). Increasing amounts of potassium iodide (final concentrations between 0.4 and 86 mM) were added directly to the cuvette in the absence and in the presence of ctDNA (100 mM) and the emission spectra were recorded. All solutions were allowed to equilibrate for 5 min before measurements. Fluorescence emission was recorded between 300 and 500 nm at room temperature with excitation at 295 nm. 
Cell culturing
HeLa (ATCC, CCL-2), H1299 (ATCC, CRL-5803) and MDA-MB-231 cells (ATCC, HTB-26) grown in Dulbecco's Modified Eagle Medium-F12 (DMEM-F12, Sigma-Aldrich, #D0547) containing 5% FBS (Biochrom, #S0415) and penicillin (100 units/mL) and streptomycin (100 mg/mL) (Biochrom, #A2212) in a 37 C, 5% CO 2 incubator.
Microscopic imaging for morphological changes
8 Â 10 3 HeLa, H1299 and MDA-MB-231 cells were seeded on 96 well plates. The day after seeding, cells were treated in serial dilutions of complexes 2, 3 and 4 (all freshly prepared in cell culture medium), added on the cells, and incubated for 24, 48 or 72 h. The experiment was repeated at two independent times with all cell lines. Images were taken using Differential interference contrast (DIC) microscopy, with a Leica DMI 6000 fluorescence microscope.
2.6. TUNEL assay 5 Â 10 4 cells (HeLa and MDA-MB-231) were seeded on 12 mm round cover slips, treated with freshly prepared complexes (2, 3 and 4) at 25 mM for 24 h, and fixed in 4% paraformaldehyde (15 min, RT). "In Situ Cell Death Detection Kit" (Roche, #11767291910) was used for detecting DNA breaks following manufacturer's instructions. The experiment was repeated at two independent times with all cell lines. Images were taken with using Leica DMI 6000 fluorescence microscope (40 X). trypsinisation and resuspended in PBS with 1% FBS at a concentration of 1 Â 10 5 cells/mL. The cells were incubated with "Annexin V/Dead Cell Reagent" (RT, 20 min, in dark). The live, dead, early and late apoptotic cells were counted with the Muse Cell Analyzer (Merck Millipore, USA).
Caspase 3/7 activity assay
1 Â 10 4 H1299 and MDA-MB-231 cells were seeded on 96 well plates. The day after seeding, cells were treated with 12.5 and 25 mM of freshly prepared complexes (2, 3 and 4) for 24 h. "Caspase-Glo® 3/ 7 Assay" (Promega, #G8091) was used for measuring caspase-3/7 activity following manufacturer's instructions. In brief, 100 mL of Caspase-Glo® 3/7 Reagent was added to each well, and the plates were incubated on shaker (RT, 300 rpm, 1 h, in dark). Total volume was transferred to white-walled 96-well plates and the luminescent signal was detected using a luminometer (FLÂ800, Bio-Tek, USA). The experiment was repeated using duplicate wells at two independent times with all cell lines, and the results are given in relative fold change to mock treated cells.
2.9. gH2AX/8-oxo-guanine staining 5 Â 10 4 MDA-MB-231 and H1299 cells were seeded on 12 mm round cover slips. The next day, cells were treated with 12.5 and 25 mM of complexes 2, 3 and 4, and incubated for 24 h. Cells were then fixed in 4% paraformaldehyde/PBS for 10 min, permeabilized in 0.3% (v/v) Triton-X/PBS for 10 min, and While mock treated controls exhibited very few to no TUNEL positive nuclei, drug treated cells were labelled green. blocked with 1% gelatin in PBS for 1 h. Cells were stained with gH2AX antibodies (1:400 diluted in 5% BSA/PBS, Cell Signaling mAb #9718) or 8-oxo-G antibodies (1:100, EMD Millipore, MAB3560) at þ4 C, overnight, and with appropriate secondary antibodies (1:500 diluted in 5% BSA/PBS) for 1 h, at RT. The experiment was repeated at two independent times with all cell lines. Images were taken with at 100 X magnification using Leica DMI 6000 fluorescence microscope.
2.10. DCFDA (2 0 ,7 0 edichlorofluorescin diacetate) analysis 8 Â 10 3 H1299 and MDA-MB-231 cells were seeded on 96 well plates. The day after seeding, cells were treated in serial dilutions of freshly prepared complexes (2, 3 and 4) and incubated for 24 h. The following day, DCFDA solution (Sigma-Aldrich, #D6883, in PBS) was added on the cells at a final concentration of 5 mM and incubated for 20 min at 37 C in 5% CO2 incubator. Plates were read at 485 nm (excitation), 535 nm (emission) wavelength using a microplate reader (Biotek Instruments Inc.). The experiment was repeated at two independent times with all cell lines. Fluorescein intensity was normalized to the number of the cells. ɣH2AX positive cells become evident following drug treatment. DNA is labelled with blue, and ɣH2AX is labelled with green flurescence.
COMET assay
Dose-Response Relationship: 4 Â 10 4 cells (MDA-MB-231 and H1299) were seeded on 24 well plates. The following day, complexes 2, 3 and 4 were prepared fresh in culture medium (12.5 and 25 mM), added on the cells, and incubated at 37 C, in 5% CO2 for 24 h. 'Ethyl methanesulfonate' (EMS, Merck-Millipore, #8.20774.0005, 40 mM, 1 h) was used as positive control. PBS was used as negative control. At the end of treatment, cells were trypsinized, and suspended at a concentration of 1.6 Â 10 4 cells/mL.
Cell lysis and electrophoresis: The cell suspensions were mixed with low melting agarose (1:3) and spread over the slide. Following jellification of the agarose, the slides were submerged in a covered dish containing lysis solution overnight (18e20 h, 4 C, dark). The day after, the slides were washed three times (20 min, in alkaline carrier buffer (pH ! 13)), submerged in fresh alkaline solution, electrophoresed (25 min, 13 V, 0.03 mA), washed with distilled water, and stained with propidium iodide (10 mg/mL, 20 min). The slides were analyzed at 535 nm/617 nm wavelength, and the images were taken under fluorescence microscope using 40 X magnification (Leica DMI 6000). final concentration of 12.5 or 25 mM and stained for ɣH2AX as described in materials and methods. Representative images are shown.
ɣH2AX positive cells become evident following drug treatment. DNA is labelled with blue, and ɣH2AX is labelled with green flurescence.
Quantitative and qualitative evaluation method: For 'DNA Tail %' calculation, 'head part density' and 'tailing part density' areas were marked using NIH Image J software. The results obtained were 
